Section 1 - CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

PRODUCT NAME

UNASCO TEFLON FIBRE REINFORCED THREADSEALING COMPOUND

NFPA

PRODUCT USE

Teflon reinforced sealing compound for threaded joints in pipe.

SYNONYMS

"thread sealant containing PTFE", "pipe joint sealant with teflon"

Section 2 - HAZARDS IDENTIFICATION

CANADIAN WHMIS SYMBOLS

EMERGENCY OVERVIEW

RISK

POTENTIAL HEALTH EFFECTS

ACUTE HEALTH EFFECTS

SWALLOWED

  There is some evidence to suggest that this material can cause, if swallowed once, irreversible damage of organs.  Ingestion of ethanol (ethyl alcohol, "alcohol") may produce nausea, vomiting, bleeding from the digestive tract, abdominal pain, and diarrhea. Effects on the body:  
Blood concentration
Effects
<1.5 g/L
Mild: impaired vision, co-ordination and reaction time; emotional instability
1.5-3.0 g/L
Moderate: Slurred speech, confusion, inco-ordination, emotional instability, disturbances in perception and senses, possible blackouts, and impaired objective performance in standardized tests. Possible double vision, flushing, fast heart rate, sweating and incontinence. Slow breathing may occur rarely and fast breathing may develop in cases of metabolic acidosis, low blood sugar and low blood potassium. Central nervous system depression may progress to coma.
3-5 g/L
Severe: cold clammy skin, low body temperature and low blood pressure. Atrial fibrillation and heart block have been reported. Depression of breathing may occur, respiratory failure may follow serious poisoning, choking on vomit may result in lung inflammation and swelling. Convulsions due to severe low blood sugar may also occur. Acute liver inflammation may develop.
  
  .  Central nervous system (CNS) depression may include general discomfort, symptoms of giddiness, headache, dizziness, nausea, anaesthetic effects, slowed reaction time, slurred speech and may progress to unconsciousness. Serious poisonings may result in respiratory depression and may be fatal.  Ingestion of propylene glycol produced reversible central nervous system depression in humans following ingestion of 60 ml. Symptoms included increased heart-rate (tachycardia),  excessive sweating (diaphoresis) and grand mal seizures in a 15 month child who ingested large doses (7.5 ml/day for 8 days) as an ingredient of vitamin preparation.  Excessive repeated ingestions may cause hypoglycaemia (low levels of glucose in the blood stream) among susceptible individuals; this may result in muscular weakness, incoordination and mental confusion.  Very high doses given during feeding studies to rats and dogs produce central nervous system depression (although one-third of that produced by ethanol), haemolysis and insignificant kidney changes.  In humans propylene glycol is partly excreted unchanged in the urine and partly metabolised as lactic and pyruvic acid. Lactic acidosis may result.  

EYE

  There is some evidence to suggest that this material can causeeye irritation and damage in some persons.  

SKIN

  There is some evidence to suggest that this material can cause inflammation of the skin on contact in some persons.  Skin contact is not thought to produce harmful health effects (as classified using animal models). Systemic harm, however, has been identified following exposure of animals by at least one other route and the material may still produce health damage following entry through wounds, lesions or abrasions. Good hygiene practice requires that exposure be kept to a minimum and that suitable gloves be used in an occupational setting.  Entry into the blood-stream, through, for example, cuts, abrasions or lesions, may produce systemic injury with harmful effects. Examine the skin prior to the use of the material and ensure that any external damage is suitably protected.  

INHALED

  Inhalation may produce health damage*.  Inhalation of vapors or aerosols (mists, fumes), generated by the material during the course of normal handling, may be damaging to the health of the individual.  The material is not thought to produce respiratory irritation (as classified using animal models). Nevertheless inhalation of the material, especially for prolonged periods, may produce respiratory discomfort and occasionally, distress.  Fumes from burning PTFE-containing materials are irritating to the upper respiratory tract and may be harmful if exposure is prolonged. When heated for a long time a very small amount of hydrogen fluoride, carbonyl fluoride and perfluoroisobutylene is generated. The higher the temperature the greater is the decomposition rate.  Symptoms of exposure to hydrogen fluoride and carbonyl fluoride include burning sensation,  cough, dizziness, headache, labored breathing, nausea, shortness of breathe, sore throat and vomiting. Symptoms may be delayed. These substances are corrosive to the eyes, skin and respiratory tract. Inhalation may produce lung oedema. Prolonged exposures may produce hypocalcaemia High exposures may be fatal. Medical observation is indicated in the event of such exposures.  Symptoms of exposure to perfluoroisobutylene include cough, shortness of breathe, sore throat. Symptoms may be delayed. Symptoms of lung oedema often do not manifest until a few hours have passed and may be aggravated by physical effort. Rest and medical observation are essential. Immediate administration of an appropriate spray, or by the doctor authorised by him/ her, should be considered.  Overheated or burnt PTFE evolves highly irritating and corrosive hydrogen fluoride gas with small amounts of highly toxic carbonyl fluoride. Polymer decomposition starts at 400 deg. C. with rapid degradation at 540 deg. C.. Decomposition products are complex.  Solutions of hydrogen fluoride gas in mucous fluids form highly corrosive hydrofluoric acid so that inhalation of decomposition products can cause symptoms of choking, coughing and severe eye, nose and throat irritation. After a symptomless period of 1-2 days, exposed individuals may experience a set of symptoms described as "polymer fume fever"; this is a temporary flu-like illness with fever, chills and, sometimes, a cough and difficult breathing which lasts for approximately 24 hours.  Inhalation or skin contact with carbonyl fluoride vapour may cause irritation with discomfort and rash. In addition, carbonyl fluoride vapours may produce eye corrosion with corneal and conjunctival ulceration, nose and throat irritation, or temporary irritation of the lungs producing cough discomfort, difficult breathing and shortness of breath.  Individuals with pre-existing lung diseases may have increased susceptibility to the toxic effects of thermal decomposition products.  The most common signs of inhalation overexposure to ethanol, in animals, include ataxia, incoordination and drowsiness for those surviving narcosis. The narcotic dose for rats, after 2 hours of exposure, is 19260 ppm.  Effects on lungs are significantly enhanced in the presence of respirableparticles.  Not normally a hazard due to non-volatile nature of product.  

CHRONIC HEALTH EFFECTS

  Limited evidence suggests that repeated or long-term occupational exposure may produce cumulative health effects involving organs or biochemical systems.  There has been some concern that this material can cause cancer or mutations but there is not enough data to make an assessment.  There is limited evidence that, skin contact with this product is more likely to cause a sensitization reaction in some persons compared to the general population.  Prolonged exposure to ethanol may cause damage to the liver and cause scarring. It may also worsen damage caused by other agents. Large amounts of ethanol taken in pregnancy may result in "fetal alcohol syndrome", characterized by delay in mental and physical development, learning difficulties, behavioral problems and small head size. A small number of people develop allergic reactions to ethanol, which include eye infections, skin swelling, shortness of breath, and itchy rashes with blisters.  Repeated exposures, in an occupational setting, to high levels of fine- divided dusts may produce a condition known as pneumoconiosis which is the lodgement of any inhaled dusts in the lung irrespective of the effect. This is particularly true when a significant number of particles less than 0.5 microns (1/50,000 inch), are present. Lung shadows are seen in the X-ray. Symptoms of pneumoconiosis may include a progressive dry cough, shortness of breath on exertion, increased chest expansion, weakness and weight loss. As the disease progresses the cough produces a stringy mucous, vital capacity decreases further and shortness of breath becomes more severe. Pneumoconiosis is the accumulation of dusts in the lungs and the tissue reaction in its presence. It is further classified as being of noncollagenous or collagenous types. Noncollagenous pneumoconiosis, the benign form, is identified by minimal stromal reaction, consists mainly of reticulin fibres, an intact alveolar architecture and is potentially reversible.  Long term exposure to titanium and several of its compounds produces lung scarring and chronic bronchitis. Breathing is impaired and cardiac changes with right heart enlargements occur. There is an increased chance of developing cancers of the respiratory tract.